Clinical Report: Reconstruction of Fenestration in Cases of Early Fontan Decline
Overview
This study evaluates the long-term clinical and hemodynamic outcomes of fenestration recreation in Fontan patients with spontaneous fenestration closure. The findings suggest that recreation may improve hemodynamic status and reduce morbidity in select patients.
Background
The Fontan procedure is a critical surgical intervention for patients with single-ventricular physiology, yet it is associated with long-term complications. Fenestration has been shown to provide hemodynamic benefits, but its persistence can lead to adverse outcomes. Understanding the implications of fenestration management is essential for optimizing patient care in this population.
Data Highlights
Group
Patients
Follow-up Duration
Fenestration Recreation
19
≥ 3 years
No Recreation
43
≥ 3 years
Key Findings
62 patients with spontaneous fenestration closure were analyzed.
Group 1 (fenestration recreation) showed improved hemodynamic parameters compared to Group 2 (no recreation).
Longitudinal hemodynamic changes were assessed over three intervals: early-term, mid-term, and late-term.
All-cause mortality was a primary outcome, with secondary outcomes including Fontan-associated morbidities.
Recreation of fenestration may reduce the risk of adverse events in select patients.
Clinical Implications
Clinicians should consider fenestration recreation as a potential intervention for Fontan patients experiencing clinical decline due to spontaneous closure. Careful patient selection and monitoring of hemodynamic parameters are crucial for optimizing outcomes.
Conclusion
The study highlights the potential benefits of fenestration recreation in improving clinical and hemodynamic outcomes in Fontan patients. Further research is warranted to refine patient selection criteria and management strategies.
A cohort study showed that patients with melanoma who received BRAF or MEK inhibitor therapy commonly experienced hypertension and mild cardiac dysfunction, supporting baseline cardiotoxicity risk str...
